Oxidative stress (OS) plays a pivotal role in the pathogenesis of age-related macular degeneration (AMD) and other ocular disorders. Mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) offer a promising, cell-free therapeutic approach due to their antioxidant and regenerative properties. To generate clinical-grade MSCs from human umbilical cord (hUC) tissue and evaluate the regenerative potential of their EVs in an in vitro AMD model. Ethical approval was obtained for processing human umbilical cord (hUC) tissue. MSCs were isolated and characterized by Immunophenotyping, immunocytochemical staining, trilineage differentiation, population doubling time and number, gene expression profiling for proliferation and cell cycle progression, a senescence-associated ß-galactosidase assay, human telomerase reverse transcriptase (hTERT) expression, and detection of mycoplasma, cytomegalovirus, and endotoxin. EVs were isolated from hUC-MSCs by differential centrifugation and characterized using fluorescence microscopy, scanning electron microscopy (SEM), atomic force microscopy (AFM), and dynamic light scattering (DLS). Oxidative stress was induced in RPE cells, as confirmed by the H2DCFDA assay, and the therapeutic effects of EVs were subsequently evaluated. Analysis of pluripotent gene markers Oct4, Sox2, and Nanog in hUC-MSCs revealed no significant differences in culture conditions. The immunophenotypic markers CD90, CD73, CD105, CD44, vimentin, CD29, Stro-1, and Lin28 were positively expressed by MSCs. Proliferative gene expressions of Pax6, BMP2, and TGFb1 showed no significant variation between hUC-MSC groups. Nevertheless, a significant increase (P < 0.001) in the mitotic phase of the cell cycle was observed in hUC-MSCs. Cellular senescence markers (hTERT expression and ß-galactosidase activity) did not show any negative effect on hUC-MSCs. Additionally, quality control assessments consistently confirmed the absence of mycoplasma, cytomegalovirus, and endotoxin. DLS, SEM, and AFM topography revealed vesicles with an average size of 181.65 ± 11.49 nm and a zeta potential of -10.31 ± 1.692 mV. Treatment with EVs significantly reduced intracellular ROS in RPE, restored cell viability, and promoted migration and proliferation. Uptake experiments confirmed efficient internalization of EVs by RPE. The scratch assay demonstrated accelerated wound closure in EV-treated groups. Gene expression analysis further showed that EVs upregulate oxidative stress markers, indicating a protective effect against oxidative damage. MSC-derived EVs demonstrate potent antioxidant and regenerative effects on RPE cells, supporting their potential as a safe, cell-free therapy for AMD. This approach may overcome limitations of stem cell transplantation and accelerate clinical translation in ophthalmology.